Progress and Challenges in the Development of COVID-19 Vaccines and Current Understanding of SARS-CoV-2-Specific Immune Responses

被引:12
|
作者
Kim, Kyun-Do [1 ]
Hwang, Insu [1 ]
Ku, Keun Bon [1 ]
Lee, Sumin [1 ]
Kim, Seong-Jun [1 ]
Kim, Chonsaeng [1 ]
机构
[1] Korea Res Inst Chem Technol, Ctr Convergent Res Emerging Virus Infect, Daejeon 34114, South Korea
关键词
COVID-19; SARS-CoV-2; Coronavirus; vaccine; immune response; RESPIRATORY-SYNDROME-CORONAVIRUS; NEUTRALIZING ANTIBODIES; INFLAMMATORY CYTOKINES; SARS; ACTIVATION; RECEPTORS; INFECTION; SPIKE; INTERFERON; EXPRESSION;
D O I
10.4014/jmb.2006.06006
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is spreading globally, and the WHO has declared this outbreak a pandemic. Vaccines are an effective way to prevent the rapid spread of COVID-19. Furthermore, the immune response against SARS-CoV-2 infection needs to be understood for the development of an efficient and safe vaccine. Here, we review the current understanding of vaccine targets and the status of vaccine development for COVID-19. We also describe host immune responses to highly pathogenic human coronaviruses in terms of innate and adaptive immunities.
引用
收藏
页码:1109 / 1115
页数:7
相关论文
共 50 条
  • [31] SARS-CoV-2/COVID-19 Vaccines: The Promises and the Challenges Ahead
    Baldo, Vincenzo
    Reno, Chiara
    Cocchio, Silvia
    Fantini, Maria Pia
    VACCINES, 2021, 9 (01)
  • [32] SARS-CoV-2-specific immunity in immunosuppressed COVID-19 convalescents with autoimmune hepatitis
    Kirchner, Theresa
    Jaeckel, Elmar
    Falk, Christine S.
    Eiz-Vesper, Britta
    Taubert, Richard
    JOURNAL OF HEPATOLOGY, 2021, 75 (06) : 1506 - 1509
  • [33] Omicron variant of SARS-CoV-2: Genomics, transmissibility, and responses to current COVID-19 vaccines
    Araf, Yusha
    Akter, Fariya
    Tang, Yan-dong
    Fatemi, Rabeya
    Parvez, Md Sorwer Alam
    Zheng, Chunfu
    Hossain, Md Golzar
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (05) : 1825 - 1832
  • [34] SARS-CoV-2 specific immune responses in overweight and obese COVID-19 patients
    Onyango, Therese Bredholt
    Zhou, Fan
    Bredholt, Geir
    Brokstad, Karl A.
    Lartey, Sarah
    Mohn, Kristin G. -I.
    Ozgumus, Turkuler
    Kittang, Bard Reiakvam
    Linchausen, Dagrun Waag
    Shafiani, Shahin
    Elyanow, Rebecca
    Blomberg, Bjorn
    Langeland, Nina
    Cox, Rebecca Jane
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [35] SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
    Le Bert, Nina
    Tan, Anthony T.
    Kunasegaran, Kamini
    Tham, Christine Y. L.
    Hafezi, Morteza
    Chia, Adeline
    Chng, Melissa Hui Yen
    Lin, Meiyin
    Tan, Nicole
    Linster, Martin
    Chia, Wan Ni
    Chen, Mark I-Cheng
    Wang, Lin-Fa
    Ooi, Eng Eong
    Kalimuddin, Shirin
    Tambyah, Paul Anantharajah
    Low, Jenny Guek-Hong
    Tan, Yee-Joo
    Bertoletti, Antonio
    NATURE, 2020, 584 (7821) : 457 - +
  • [36] SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
    Nina Le Bert
    Anthony T. Tan
    Kamini Kunasegaran
    Christine Y. L. Tham
    Morteza Hafezi
    Adeline Chia
    Melissa Hui Yen Chng
    Meiyin Lin
    Nicole Tan
    Martin Linster
    Wan Ni Chia
    Mark I-Cheng Chen
    Lin-Fa Wang
    Eng Eong Ooi
    Shirin Kalimuddin
    Paul Anantharajah Tambyah
    Jenny Guek-Hong Low
    Yee-Joo Tan
    Antonio Bertoletti
    Nature, 2020, 584 : 457 - 462
  • [37] Persistent COVID-19 Symptoms Minimally Impact the Development of SARS-CoV-2-Specific T Cell Immunity
    Fang, Hengsheng
    Wegman, Adam D.
    Ripich, Kianna
    Friberg, Heather
    Currier, Jeffrey R.
    Thomas, Stephen J.
    Endy, Timothy P.
    Waickman, Adam T.
    VIRUSES-BASEL, 2021, 13 (05):
  • [38] Post-COVID-19 sequelae are associated with sustained SARS-CoV-2-specific CD4+immune responses
    Venegoni, Chiara
    Raineri, Davide
    Mazzucca, Camilla Barbero
    Ghazanfar, Ali
    Cappellano, Giuseppe
    Baricich, Alessio
    Patrucco, Filippo
    Zeppegno, Patrizia
    Gramaglia, Carla
    Balbo, Piero Emilio
    Cantaluppi, Vincenzo
    Patti, Giuseppe
    Giordano, Mara
    Manfredi, Marcello
    Rolla, Roberta
    Sainaghi, Pier Paolo
    Pirisi, Mario
    Bellan, Mattia
    Chiocchetti, Annalisa
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2025, 148
  • [39] Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients
    Mansi, Laura
    Spehner, Laurie
    Daguindau, Etienne
    Bouiller, Kevin
    Almotlak, Hamadi
    Stein, Ulrich
    Bouard, Adeline
    Kim, Stefano
    Klajer, Elodie
    Jary, Marine
    Meynard, Guillaume
    Vienot, Angelique
    Nardin, Charlee
    Bazan, Fernando
    Lepiller, Quentin
    Westeel, Virginie
    Adotevi, Olivier
    Borg, Christophe
    Kroemer, Marie
    EUROPEAN JOURNAL OF CANCER, 2021, 150 : 1 - 9
  • [40] Bamlanivimab therapy for acute COVID-19 does not blunt SARS-CoV-2-specific memory T cell responses
    Ramirez, Sydney I.
    Grifoni, Alba
    Weiskopf, Daniela
    Parikh, Urvi M.
    Heaps, Amy
    Faraji, Farhoud
    Sieg, Scott F.
    Ritz, Justin
    Moser, Carlee
    Eron, Joseph J.
    Currier, Judith S.
    Klekotka, Paul
    Sette, Alessandro
    Wohl, David A.
    Daar, Eric S.
    Hughes, Michael D.
    Chew, Kara W.
    Smith, Davey M.
    Crotty, Shane
    JCI INSIGHT, 2022, 7 (24)